Efficacies of Different Managements in Patients With Trigger Finger

This study was designed as a randomized, controlled, prospective study. Patients who had been experiencing trigger finger symptoms for at least one month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, affiliated with the Health Sciences University Faculty of Medicine

Patients were randomly divided into two groups: the peritendinous steroid group (n=15) and the percutaneous pulley release group (n=15). In the first group, under ultrasound guidance, a mixture of 1 ml corticosteroid (2 mg+5 mg/ml betamethasone) and 1 ml local anesthetic (20 ml 2% prilocaine) was injected peritendinously between the A1 pulley and the flexor tendon sheath. In the second group, a percutaneous A1 pulley release procedure was performed under ultrasound guidance using a 20 G needle, followed by peritendinous injection of the same mixture of corticosteroid and local anesthetic.

Patients were evaluated four times: before treatment, at 1 week, 1 month, and 3 months after treatment. Modified Quinnel classification, VAS (Visual Analog Scale), and severity of locking scales were used as outcome measures in the study.

Inclusion criteria

• Being over 18 years of age
• Having had trigger finger complaints for more than 1 month
• Not having received any injections for trigger finger diagnosis within the last 1 month
• Signing the informed consent form indicating willingness to participate in the study

Exclusion criteria

• Refusing to participate in the study
• Presence of partial or complete tendon rupture in the relevant tendon of the finger to be treated
• Presence of wounds and infection in the area where the procedure will be performed
• Pregnancy status
• History of allergy to the injected medications (local anesthetic, steroid)